nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal expression or mutation of TP53 and HPV in vulvar cancer
|
Ngan, H.Y.S |
|
1999 |
35 |
3 |
p. 481-484 4 p. |
artikel |
2 |
A Possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier
|
Št’astný, M. |
|
1999 |
35 |
3 |
p. 459-466 8 p. |
artikel |
3 |
Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma?
|
Heiss, M.M |
|
1999 |
35 |
3 |
p. 353-358 6 p. |
artikel |
4 |
Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma?
|
Marquet, R.L. |
|
1999 |
35 |
3 |
p. 352-353 2 p. |
artikel |
5 |
Are allogenic blood transfusions acceptable in elective surgery in colorectal carcinoma?
|
Amato, A.C. |
|
1999 |
35 |
3 |
p. 358-360 3 p. |
artikel |
6 |
Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-α-2c in patients with advanced colorectal cancer: final results of a randomised phase III study
|
Hausmaninger, H |
|
1999 |
35 |
3 |
p. 380-385 6 p. |
artikel |
7 |
Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?
|
Tierney, J.F |
|
1999 |
35 |
3 |
p. 406-409 4 p. |
artikel |
8 |
Correspondence
|
|
|
1999 |
35 |
3 |
p. 521-522 2 p. |
artikel |
9 |
Correspondence
|
|
|
1999 |
35 |
3 |
p. 522-524 3 p. |
artikel |
10 |
Correspondence
|
|
|
1999 |
35 |
3 |
p. 521- 1 p. |
artikel |
11 |
CPT-11 in gastrointestinal cancer
|
Bleiberg, H |
|
1999 |
35 |
3 |
p. 371-379 9 p. |
artikel |
12 |
Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix
|
de Gruijl, T.D |
|
1999 |
35 |
3 |
p. 490-497 8 p. |
artikel |
13 |
Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma
|
Meister, B |
|
1999 |
35 |
3 |
p. 445-449 5 p. |
artikel |
14 |
Familial risks in second primary breast cancer based on a family cancer database
|
Hemminki, K |
|
1999 |
35 |
3 |
p. 455-458 4 p. |
artikel |
15 |
FHIT Gene Abnormalities in Both Benign and Malignant Thyroid Tumours
|
Zou, M |
|
1999 |
35 |
3 |
p. 467-472 6 p. |
artikel |
16 |
Fluorescent in situ hybridisation (FISH) characterisation of pericentromeric breakpoints on chromosome 5 in head and neck squamous cell carcinomas
|
Martins, C. |
|
1999 |
35 |
3 |
p. 498-501 4 p. |
artikel |
17 |
Genetic pathways in colorectal and other cancers
|
Ilyas, M. |
|
1999 |
35 |
3 |
p. 335-351 17 p. |
artikel |
18 |
Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells
|
Kim, S.E. |
|
1999 |
35 |
3 |
p. 507-511 5 p. |
artikel |
19 |
Guidelines for anti-emetic therapy: acute emesis
|
Fauser, A.A. |
|
1999 |
35 |
3 |
p. 361-370 10 p. |
artikel |
20 |
Mammography requests in general practice during the introduction of nationwide breast cancer screening, 1988–1995
|
Beemsterboer, P.M.M |
|
1999 |
35 |
3 |
p. 450-454 5 p. |
artikel |
21 |
Melanoma cell-derived factor stimulation of fibroblast glycosaminoglycan synthesis—The role of platelet-derived growth factor
|
Godden, J.L |
|
1999 |
35 |
3 |
p. 473-480 8 p. |
artikel |
22 |
Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?
|
Braud, A.C |
|
1999 |
35 |
3 |
p. 392-397 6 p. |
artikel |
23 |
Pilomatrix carcinoma with multiple metastases: report of a case and review of the literature
|
Bremnes, R.M. |
|
1999 |
35 |
3 |
p. 433-437 5 p. |
artikel |
24 |
Population density and childhood leukaemia: results of the EUROCLUS study
|
Alexander, F.E. |
|
1999 |
35 |
3 |
p. 439-444 6 p. |
artikel |
25 |
Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses
|
Mirallié, E |
|
1999 |
35 |
3 |
p. 420-423 4 p. |
artikel |
26 |
Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients
|
Kucera, E. |
|
1999 |
35 |
3 |
p. 398-405 8 p. |
artikel |
27 |
Quality of adjuvant chemotherapy in primary breast cancer in a non-trial setting. A comprehensive cancer centre study
|
Ottevanger, P.B. |
|
1999 |
35 |
3 |
p. 386-391 6 p. |
artikel |
28 |
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment
|
Berthet, B |
|
1999 |
35 |
3 |
p. 413-419 7 p. |
artikel |
29 |
Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic
|
Fridborg, H |
|
1999 |
35 |
3 |
p. 424-432 9 p. |
artikel |
30 |
Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts
|
Hill, B.T |
|
1999 |
35 |
3 |
p. 512-520 9 p. |
artikel |
31 |
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
|
Woll, P.J |
|
1999 |
35 |
3 |
p. 410-412 3 p. |
artikel |
32 |
Thrombospondin-2 (TSP2) expression is inversely correlated with vascularity in glioma
|
Kazuno, M |
|
1999 |
35 |
3 |
p. 502-506 5 p. |
artikel |
33 |
Vascular endothelial growth factor is implicated in early invasion in cervical cancer
|
Kodama, J |
|
1999 |
35 |
3 |
p. 485-489 5 p. |
artikel |